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Abstract: We investigated the involvement of glycogen synthase kinase-3β (GSK3β) and the
voltage-dependent anion channel (VDAC) in livers subjected to cold ischemia–reperfusion injury
(I/R) associated with orthotopic liver transplantation (OLT). Rat livers were preserved in University
of Wisconsin (UW) and Institute Georges Lopez (IGL-1) solution, the latter enriched or not with
trimetazidine, and then subjected to OLT. Transaminase (ALT) and HMGB1 protein levels, glutamate
dehydrogenase (GLDH), and oxidative stress (MDA) were measured. The AKT protein kinase
and its direct substrates, GSK3β and VDAC, as well as caspases 3, 9, and cytochrome C and
reticulum endoplasmic stress-related proteins (GRP78, pPERK, ATF4, and CHOP), were determined
by Western blot. IGL-1+TMZ significantly reduced liver injury. We also observed a significant
phosphorylation of AKT, which in turn induced the phosphorylation and inhibition of GSK3β.
In addition, TMZ protected the mitochondria since, in comparison with IGL-1 alone, we found
reductions in VDAC phosphorylation, apoptosis, and GLDH release. All these results were correlated
with decreased ER stress. Addition of TMZ to IGL-1 solution increased the tolerance of the liver graft
to I/R injury through inhibition of GSK3β and VDAC, contributing to ER stress reduction and cell
death prevention.
Keywords: IGL-1 preservation solution; trimetazidine; liver transplantation; ischemia–reperfusion
injury; GSK3β; VDAC; ER stress
1. Introduction
Cold ischemia–reperfusion (I/R) injury is a major cause of primary graft non-function after liver
transplantation (LT) [1]. As a preservation solution, the European Liver Transplant Registry, proposed
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IGL-1 as a good alternative to UW, until now the reference solution in liver transplantation [2]. The
composition of the preservation solution is crucial for the viability of liver grafts kept for prolonged
ischemic periods [3]. The benefits of IGL-1 solution are mainly associated with the nitric oxide
generation and the prevention of endoplasmic reticulum (ER) stress and inflammatory response [4].
In addition, in previous publications, we have shown that the use of additives such as
trimetazidine (TMZ) to UW [5,6] and IGL-1 solutions [7,8] contributes to increasing the preservation of
steatotic liver grafts (which are more vulnerable than non-steatotic ones) against cold I/R injury [9].
More recently, we proved that the presence of TMZ in IGL-1 solution increases the liver graft protection
against cold I/R associated with orthotopic liver transplantation (OLT) by promoting effective
prevention of mitochondrial damage [10]. However, the underlying mechanisms of mitochondrial
protection responsible for these IGL-1 benefits have not been fully investigated.
Glycogen synthase kinase-3β (GSK3β) is a serine/threonine kinase that participates in the
regulation of many cell functions. Its activity is controlled by multiple mechanisms, including
its phosphorylation and intracellular translocation. GSK3β is active in its dephosphorylated form,
showing a pleiotropic function in the regulation of cell activation, differentiation, and apoptosis [11,12].
In addition, GSK3β is responsible for the phosphorylation of the voltage-dependent anion channel
(VDAC), the major resident protein of the outer membrane of the liver mitochondria [13–15]. VDAC
forms the primary passage for ions and metabolites between mitochondria and cytosol and it is also
involved in programmed cell death regulation [13,16].
GSK3β has been implicated in liver I/R pathophysiology. Its inhibition improves liver
microcirculation and hepatocellular function after hemorrhagic shock [17]. In addition, its
phosphorylation has been implicated in the hepatoprotection induced by ischemic preconditioning
against I/R [18]. In a previous study [19], our group described the mitochondrial protection
mechanisms involved in this process. More recently, a relationship between GSK3β and ER stress has
been evidenced in a pancreatitis model [20]. That study demonstrated that Valproate pretreatment
protects pancreatic β-cells from palmitate-induced ER stress and apoptosis by inhibiting GSK3β.
Despite the crucial role of GSK3β in a range of pathologies, its involvement in cold I/R associated
with liver transplantation remains unclear. Thus, understanding its role in the physiopathology of
cold I/R will enhance our knowledge of the basic mechanisms underlying the pathogenesis of this
disorder and is likely to aid the identification of new therapeutic avenues.
In this report we assessed the effect of GSK3β modulation by trimetazidine, as an additive in
IGL-1 solution, for enhancing liver graft preservation followed by OLT. We also evaluated the relevance
of GSK3β inhibition during cold storage for the modulation of ER stress and mitochondrial damage.
2. Results
In this study we evaluated whether the addition of trimetazidine to IGL-1 solution protected
liver grafts against cold I/R associated with liver transplantation, and whether this protection might
be mediated by changes in the protein levels of AKT and its direct substrate GSK3β after 8 h of
ischemic cold storage followed by 24 h orthotopic liver transplantation. As indicated in Figure 1A,
phosphorylated AKT (p-AKT) levels were similar in sham livers and in livers preserved with UW. This
was associated with a decrease in the protein levels of phosphorylated GSK3β (p-GSK3β), the inactive
form of GSK3β, in livers preserved in UW solution (Figure 1B). IGL-1 solution increased p-GSK3β
compared with UW; however, addition of TMZ to IGL-1 solution increased p-AKT protein levels,
which were correlated with reduced GSK3β activity by increasing its phosphorylation (Figure 1A,B).
Total AKT and GSK3β were unchanged in all groups.
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Figure 1. AKT, GSK3β, and VDAC protein levels after transplantation. Representative Western blot 
at the top and densitometric analysis at the bottom of total and phospho-AKT (A), total and phospho-
GSK3β (B) and phospho-VDAC (C). UW: liver preserved in UW solution; IGL-1: liver preserved in 
IGL-1 solution; IGL-1+TMZ: liver preserved in IGL-1 solution with trimetazidine. a p < 0.05 vs. Sham, 
b p < 0.05 vs. UW, and c p < 0.05 vs. IGL-1. 
Figure 1. AKT, GSK3β, and VDAC protein levels after transplantation. Representative Western
blot at the top and densitometric analysis at the bottom of total and phospho-AKT (A), total and
phospho-GSK3β (B) and phospho-VDAC (C). UW: liver preserved in UW solution; IGL-1: liver
preserved in IGL-1 solution; IGL-1+TMZ: liver preserved in IGL-1 solution with trimetazidine. a p < 0.05
vs. Sham, b p < 0.05 vs. UW, and c p < 0.05 vs. IGL-1.
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In view of the potential relationship between GSK3β and VDAC, one of the major resident
proteins of the outer membrane mitochondria (the active non-phosphorylated GSK3β activates VDAC
by increasing its phosphorylation) [21], we next evaluated whether changes in GSK3β activity might
be associated with changes in mitochondrial VDAC activity. In fact we observed that phosphorylated
VDAC (p-VDAC) pattern profiles were the reverse of those obtained in p-GSK3β. As indicated in
Figure 1C we noted an increase in p-VDAC protein levels in livers preserved in UW preservation
solution when compared to sham. The addition of TMZ to IGL-1 reduced VDAC phosphorylation
when compared to UW solution and IGL-1 solution alone.
These findings were consistent with the reductions in mitochondrial damage, oxidative stress and
liver injury evidenced respectively by reductions in GLDH activity, MDA, and ALT (Table 1).
Table 1. Serum levels of ALT (Liver injury) and GLDH (mitochondrial damage) and lipid peroxidation
(MDA) in liver grafts preserved in UW, IGL-1 and IGL-1+TMZ solutions and then subjected to
orthotopic liver transplantation. a p < 0.05 vs. Sham; b p < 0.05 vs. UW; and c p < 0.05 vs. IGL-1.
Parameters Sham UW IGL-1 IGL-1+TMZ
ALT (U/I) 56.12 ± 34.25 565.24 ± 63.73 a 278.87 ± 61.37 a,b 164.14 ± 18.84 a,b,c
GLDH (U/I) 9.13 ± 2.45 131.72 ± 15.26 a 92.21 ± 11.75 a,b 42.78 ± 7.97 a,b,c
MDA (nmol/mg prot) 0.4 ± 0.16 2.55 ± 0.55 a 1.87 ± 0.33 a,b 1.2 ± 0.29 a,b,c
Since the mitochondrial alteration was generally correlated with apoptotic cell death after liver
transplantation, we evaluated the changes in protein levels of cytochrome C and cleaved caspase 3
and 9 as well as the percentage of TUNEL-positive cells. Our results indicated that the activation of
GSK3β and VDAC in UW group was in accordance with the increased protein levels of cytochrome C
and cleaved caspase 3 and 9 compared with the sham group (Figure 2A–C). Although the release of
cytochrome C was prevented more in IGL-1 than UW, the lowest levels were observed when TMZ was
added to IGL-1 (Figure 2A). This was also confirmed by the fall in the percentage of TUNEL-positive
cells as well as in cleaved caspases 3 and 9 in the IGL-1+TMZ group compared with UW and IGL-1
groups (Figure 2B–D). These results suggest that the inactivation of GSK3β phosphorylation could
modulate VDAC activity, thus reducing cytochrome C release and caspase 3 and 9 cleavage.
There is growing evidence that perturbations in the endoplasmic reticulum (ER) are novel
subcellular effectors, possibly involved in the promotion of cell death during cold organ
preservation [22]. For this reason we evaluated the effects of the different solutions on ER stress.
We assessed hepatic protein levels of GRP78, phospho-PERK (p-PERK), ATF4, and CHOP by Western
blotting. Our results demonstrated increased levels of GRP 78 (Figure 3A) and p-PERK (Figure 3B)
concomitantly with ATF4 and CHOP accumulation (Figure 3C,D) when UW solution was used.
However, the activation of GRP78, p-PERK, ATF4, and CHOP was significantly lower in the IGL-1
solution and was prevented even further by the addition of TMZ to IGL-1 solution (Figure 3A–D).
The benefits of ER stress reduction achieved by using TMZ as an additive to IGL-1 were correlated
with an increased expression of other cytoprotective factors such as HO-1 and HSP70. As shown in
Figure 4, the increases in HO-1 and HSP70 protein levels occurred in livers preserved in IGL-1 enriched
with TMZ were larger than those achieved with UW or IGL-1 alone.
Finally, because of the association of inflammatory response and hepatocellular damage in liver
transplantation with ER stress response, we explored the expression of HMGB-1, a well-known early
mediator in inflammation and liver damage after liver transplantation [23], in a histological study.
In fact we noted increased HMGB-1 protein levels in livers preserved in UW solution compared with
sham. Although the use of IGL-1 solution kept HMGB-1 protein levels down compared with UW
solution, the enrichment of IGL-1 with TMZ reduced HMGB-1 accumulation even further (Figure 5A).
This was in agreement with the histological results (Figure 5B) which demonstrated a pattern similar
to that described for HMGB-1 protein levels.
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Figure 2. Cell death after liver transplantation. Representative Western blot at the top and 
densitometric analysis at the bottom of protein levels of cytochrome C (A), cleaved caspase 9 (B), and 
cleaved caspase 3 (C) expression in liver grafts; and (D) Representative light photomicrographs of 
Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) stained sections. Livers 
submitted to Orthotopic liver transplantation (OLT) after cold storage preservation with UW (I) 
showed numerous positive cells, both hepatocytes (arrows) and sinusoidal lining cells (arrow heads). 
The positivity decreased when the livers were submitted to OLT after cold storage preservation with 
IGL-1 solution (II); The addition of TMZ to IGL-1 solution (III) induced a further reduction of TUNEL 
positivity both for hepatocytes and sinusoidal lining cells. UW: liver preserved in UW solution; IGL-
1: liver preserved in IGL-1 solution; IGL-1+TMZ: liver preserved in IGL-1 solution with trimetazidine. 
a p < 0.05 vs. Sham; b p < 0.05 vs. UW; and c p < 0.05 vs. IGL-1. CL: centrolobular vein. Scale bar (black) 
indicates 50 μm. 
Figure 2. Cell death fter liver transplantation. Representativ Western blot at the t p and d nsitometric
analysis at the bottom of protein levels f cytochrome C (A), cl aved caspase 9 (B), and cle ved
caspase 3 (C) expression in liver grafts; and (D) Representativ light photomicrographs f Terminal
deoxynucleotid l transferase dUTP nick end labeling (TUNEL) stained sectio s. Livers submitted
to Orthotopic liver transplantation (OLT) after cold s orage preservation with UW (I) showed
numerous positive cells, both hepa ocytes (arrows) and sinusoidal lining cells (arrow heads). The
positivity decreased when t livers w e submitted to OLT after cold st rage preservation with IGL-1
solution (II); The addition of TMZ to IGL-1 solution (III) induced a further f TUNEL
positivity both for hepatocytes and sinusoidal lining cel s. U : liver preserved in solution; I -1:
liver p eserved in IGL-1 solution; IGL-1+TMZ: liver preser e l tion with trimetazidine.
a p < 0.05 vs. ; . . ; c p < 0.05 vs. IGL-1. CL: centrolobular vein. Scale bar (black)
indicates 50 µm.
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Figure 3. Endoplasmic reticulum stress after liver transplantation. Representative Western blot at the 
top and densitometric analysis at the bottom of (A) GRP78, (B) total and phospho-PERK, (C) ATF4 
and (D) Chop. UW: liver preserved in UW solution; IGL-1: liver preserved in IGL-1 solution; IGL-
1+TMZ: liver preserved in IGL-1 solution with trimetazidine. a p < 0.05 vs. Sham; b p < 0.05 vs. UW; 
and c p < 0.05 vs. IGL-1. 
. l i i l li l i . i l
densitometric analysis at he bottom of (A) GRP78, (B) total and phospho-PERK, (C) ATF4 and
(D) Chop. UW: liver preserved in UW solution; IGL-1: liver pres ved in IGL-1 solution; IGL-1+TMZ:
liver preserved in IGL-1 solution with trime azidin . a p < 0.05 vs. Sham; b p < 0.05 vs. UW; and
c p < 0.05 vs. IGL-1.
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Figure 4. Representative light photomicrographs of HSP70 (A) and HO-1 (B) immunohistochemistry. 
For HSP70 (A) the positivity occurred in parenchymal cells, while non-parenchymal cells displayed 
practically no staining, and were mainly distributed in the periportal areas. Only a few scattered 
hepatocytes were positive to HSP70 staining in livers submitted to OLT after cold storage 
preservation with UW (I); the positivity increased when the livers were submitted to OLT after cold 
storage with IGL-1 solution (II), and even more when trimetazidine (IGL-1+TMZ) was added to IGL-
1 solution (III). Concerning HO-1, (B) the positivity occurred both in parenchymal cells (arrows) and 
in sinusoidal lining cells (arrow heads) and it was homogeneously distributed throughout the lobule. 
Livers submitted to OLT after cold storage preservation with UW (I) showed only scarce positivity. 
The positivity increased when the livers were submitted to OLT after cold storage preservation with 
IGL-1 solution (II). The addition of TMZ to IGL-1 solution (IGL1+TMZ) (III) induced a further 
increase of HO-1 expression both in hepatocytes and in sinusoidal lining cells. CL: centrolobular vein; 
P: portal vein. Scale bar 50 μm. 
Figure 4. Representative light photomicrographs of HSP70 (A) and HO-1 (B) immunohistochemistry.
For HSP70 (A) the positivity occurred in parenchymal cells, while non-parenchymal cells displayed
practically no staining, and were mainly distributed in the periportal areas. Only a few scattered
hepatocytes were positive to HSP70 staining in livers submitted to OLT after cold storage preservation
with UW (I); the positivity increased when the livers were submitted to OLT after cold storage with
IGL-1 solution (II), and even more when tri etazidine (IGL-1+TMZ) was added to IGL-1 solution (III).
Concerning HO-1, (B) the positivity occurred both in parenchymal cells (arrows) and in sinusoidal
lining cells (arrow heads) and it was homogeneously distributed throughout the lobule. Livers
submitted to OLT after cold storage preservation with UW (I) showed only scarce positivity. The
positivity increased when the livers were submitted to OLT after cold storage preservation with IGL-1
solution (II). The addition of TMZ t IGL-1 s lution (IGL1+TMZ) (III) induced a further increas of
HO-1 expression both in hepatocytes and in sinusoidal lining cells. CL: centrolobular vein; P: portal
vein. Sc le bar 50 µm.
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Figure 5. Inflammatory response and histological lesions in the liver. (A) Representative Western blot 
at the top and densitometric analysis at the bottom of HMBG1 protein levels; (B) Histological damage 
after liver transplantation from grafts preserved in UW (I), IGL-1 (II) and IGL-1+TMZ (III) 
preservation solutions. (I) Liver preserved in UW solution: extensive and confluent areas of 
coagulative hepatic necrosis with neutrophil infiltration; (II) Liver preserved in IGL-1 solution: 
reduced areas of coagulative hepatic necrosis with neutrophil infiltration; and (III) Liver preserved 
in IGL-1+IGL-1 solution: TMZ induced further reductions in areas of coagulative hepatic necrosis 
with neutrophil infiltration. UW: liver preserved in UW solution; IGL-1: liver preserved in IGL-1 
solution; IGL-1+TMZ: liver preserved in IGL-1 solution with trimetazidine. Scale bar (Black) indicates 
50 μm. a p < 0.05 vs. sham; b p < 0.05 vs. UW; and c p < 0.05 vs. IGL-1.  
Figure 5. Inflam ator r and histological lesions in the liver. (A) Representative Western
blot at the top and densitometric analysis at the b ttom of HMBG1 protein levels; (B) Histological
damage after liver transpla tation from grafts preserved in UW (I), IGL-1 (II) and IGL-1+TMZ (III)
preservation solutions. (I) Liver preserved in UW solution: extensive and confluent areas of coagulative
hepatic necrosis with neutrophil infiltration; (II) Liver preserved in IGL-1 solution: reduced areas of
coagulative hepatic necrosis with neutrophil infiltration; and (III) Liver preserved in IGL-1+IGL-1
solution: TMZ induced further reductions in areas of coagulative hepatic necrosis with neutrophil
infiltration. UW: liver preserved in UW solution; IGL-1: liver preserved in IGL-1 solution; IGL-1+TMZ:
liver preserved in IGL-1 solution with trimetazidine. Scale bar (Black) indicates 50 µm. a p < 0.05 vs.
sham; b p < 0.05 vs. UW; and c p < 0.05 vs. IGL-1.
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3. Discussion
It is well established today that cold I/R injury is a major cause of primary graft non-function
after liver transplantation [1]. The composition of preservation solution is crucial for the viability
of liver grafts kept for prolonged ischemic periods and then subjected to transplantation [2]. The
role of GSK3β in the pathophysiology of liver I/R injury has not been investigated thoroughly.
GSK3β is a serine/threonine kinase whose activity is inhibited by phosphorylation [12]; recently,
it was demonstrated that its inhibition improves liver microcirculation and hepatocellular function
after hemorrhagic shock [17]. A phosphorylated GSK3β increase is also involved in the adaptive
mechanisms of hepato-protection against I/R injury induced by ischemic preconditioning in the
liver [18]. Moreover, it has been reported that modulation of Akt and its downstream targets GSK3β
and VDAC could be used as a potential therapeutic strategy for protecting the kidney against I/R
injury [24].
In view of the recent data published by the European Liver Transplant Registry [2] and our
previous reports of liver preservation solutions [25], we evaluated the relevance of the AKT/GSK3β
pathway and its direct substrate VDAC in rat orthotopic liver transplantation settings using UW, IGL-1
and IGL-1+TMZ preservation solutions. Our data demonstrated, for the first time, the relevance of
GSK3β phosphorylation in liver transplantation and how its activity also depends on the preservation
solution used. In fact, the inactivation of GSK3β phosphorylation is a feature of the protection
provided by IGL-1, but not of the protection provided by to UW. The differences in phosphorylated
GSK3β could be explained by the increased p-AKT protein levels especially when TMZ was added
to IGL-1. The regulation of GSK3β by AKT is well documented [21,26]. In fact previous studies
suggested that protein kinase C and Akt are mainly responsible for GSK-3β phosphorylation in
ischemic preconditioning-induced cardioprotection [21,26]. Along the same lines, several reports
have associated the protective effect of TMZ against I/R injury with its ability to activate AKT, which
represents a major pathway mediating cell survival [27–29].
In addition, it is well established that phosphorylation of mitochondrial VDAC is a key element
of the complex network of regulatory and signaling pathways involved in mechanism for numerous
cellular processes, such as those occurring in the mitochondrial dysfunction associated with liver
transplantation [16,30]. For this reason we assessed the impact of GSK3β phosphorylation on VDAC
modulation. Our results show that TMZ addition to IGL-1 solution protected mitochondria from
the deleterious consequences of cold I/R injury via promotion of GSK3β phosphorylation and
prevention of VDAC phosphorylation. These results are in accordance with previous studies which
demonstrated that inhibition of GSK3β phosphorylation was associated with a decrease in VDAC
phosphorylation and delayed mitochondrial permeability transition pore (mPTP) opening after I/R
injury [21,30]. Furthermore, TMZ acts on mitochondria by restoring ATP synthesis and by maintaining
the impermeability of the mitochondrial membrane [31]. Indeed, TMZ might interact with VDAC
which, it has also been suggested, may control the release of cytochrome C [32]. Taken this into account,
it could be argued that the inactivation of phosphorylation of GSK3β by TMZ during cold ischemia
may facilitate hypoxic adaptation through the phosphorylation of VDAC.
Given the close relationship between mPTP opening and apoptotic cell death, we next evaluated
the key mediators of mitochondrial-induced apoptosis such as cytochrome c, cleaved caspase 3 and
9 levels and the percentage of TUNEL-positive cells. Our results indicated that IGL-1 prevented
cytochrome C release and consequently reduced caspase 3 and 9 activation when compared with UW
solution. IGL-1 enrichment with TMZ enhanced mitochondrial protection even more and inhibited
apoptosis. These results are in agreement with other data suggesting that TMZ exerts its cytoprotective
effect during early reperfusion essentially by reducing the mitochondrial dysfunction after renal
I/R [33].
More recently, ER stress alteration has been proposed as a new contributor to the poor tolerance
of livers to I/R injury [22,34]. It has been reported that ER stress is a mediator of post-transplant
injury in liver grafts, thus promoting cell death [4]. Here we demonstrate for the first time that the
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addition of TMZ to IGL-1 preservation solution reduces ER stress in liver grafts, thus enhancing
liver function after transplantation. In fact the impact of TMZ on ER stress modulation in liver graft
remains unclear. Indeed, data from another study suggest that ER stress may not be a target through
which TMZ exerts its cytoprotective effect against warm I/R in kidney [33]. The reasons for the
discrepancies in the findings of the two studies might be in part related to the differences in the organs
and experimental protocols used, including the type of ischemic injury (warm or cold). Although the
effect of TMZ on ER stress modulation was not fully explored in this study, we suggest that TMZ may
reduce ER stress via GSK3β inhibition. In fact, it is well known that ER depends on ATP to correct
the misfolding of protein errors; ATP reduction following I/R injury can lead to ER stress and cell
death [35]. Thus the enhancement of mitochondrial protection by the use of TMZ could reduce ER
stress. This finding may be supported by the demonstration of a relation between GSK3β and ER
stress in a pancreatitis model [20]. This study showed that Valproate pretreatment protects pancreatic
β-cells from palmitate-induced ER stress and apoptosis by inhibiting glycogen synthase kinase-3β [20].
Similarly, another study demonstrated that Akt activation attenuated lipopolysaccharide-induced
cardiac dysfunction via Akt/GSK3β-dependent inhibition of apoptosis and ER stress [36].
Finally, in order to assess the impact of AKT/GSK3β pathway modulation on inflammation
and liver damage after orthotopic liver transplantation we examined changes in the protein levels
of HMGB-1, an early inflammatory mediator after acute I/R injury [23,37], as well as the structural
alteration (histological study). We found that the addition of TMZ to IGL-1 reduced HMGB-1 protein
levels compared with UW and IGL-1 alone, and that this reduction was correlated with reduced
structural damage. Our results corroborate those of previous studies suggesting that inflammatory
signaling following hepatic I/R is triggered by the release of the nuclear protein HMGB-1from necrotic
or damaged cells, which acts as a proinflammatory cytokine and functions as a major stimulus of
necrosis-induced inflammation [23,38].
In summary, IGL-1 solution, especially when supplemented with TMZ, increases the tolerance of
the liver graft to I/R associated with OLT through the inhibition of GSK3β and VDAC, thus preventing
cell apoptosis. GSK3β inhibition contributes to reinforcing mitochondrial protection and leads to
reduced ER stress. The inhibition of GSK3β is an issue of growing interest in the search for new
therapeutic strategies for the prevention of I/R injury.
4. Materials and Methods
4.1. Experimental Animals
Liver transplantation protocol was applied to male Sprague–Dawley rats (250–300 g bodyweight)
under general anesthesia with isofluorane respecting the European Union rules for animal experiments
(EC-guideline 86/609/CEE) and approved by the Ethics Committees for Animal Experimentation
(CEEA)of the University of Barcelona (number 483/16).
4.2. Experimental Design
The following experimental groups were defined as follows.
Group 1 (Sham: n = 12): Sprague–Dawley rats were immediately subjected to laparotomy and the
subsequent ligation of suprarenal and diaphragmatic vein and hepatic artery, respectively. Group 2
(UW: n = 12, six transplantation): donor livers were flushed and stored in UW preservation solution
for 8 h at 4 ◦C, and then underwent OLT according to Kamada’s cuff technique without hepatic artery
construction [39,40]. Rats were sacrificed 24 h after reperfusion for liver and plasma sample collection.
Group 3 (IGL-1; n = 12, six transplantation): same as 2, but using IGL-1 preservation solution instead
of UW. Group 4 (IGL-1+TMZ: n = 12, six transplantation): same as 3, but IGL-1 was supplemented
with TMZ at 10−6 mol/L [7].
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4.3. Biochemical Determinations
4.3.1. Transaminase Assay
Hepatic injury was evaluated by alanine aminotransferase (ALT) levels using commercial kits
from RAL (Barcelona, Spain). ALT was determined at 365 nm with an Ultraviolet spectrophotometer
(Beckman Coulter, Inc., Fullerton, CA, USA) and calculated following the supplier’s instructions [41].
4.3.2. Glutamate Dehydrogenase Activity
Activity of glutamate dehydrogenase (GLDH), a mitochondrial enzyme, was used as an indirect
determination of mitochondrial damage, as previously reported [41,42].
4.3.3. Lipid Peroxidation
Liver lipoperoxides were determined by measuring the formation of malondialdehyde (MDA)
with the thiobarbiturate reaction, as previously described [42].
4.3.4. TUNEL Assay
The evaluation of DNA fragmentation was carried out by using TUNEL assay, as previously
indicated in our studies [4,8].
4.3.5. Histology
The severity of hepatic injury was assessed in the haematoxylin and eosin-stained sections by
a point-counting method using optical microscopy. Liver injury was scored on an ordinal scale as
previously reported [34].
4.3.6. Western Blotting Analysis
Liver tissue was homogenized as previously described [4,34]: 50 µg proteins were separated on
6%–15% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gels. Proteins were
blotted into polyvinylidene fluoride (PVDF) membranes (Biorad, Madrid, Spain) and immunoblotted
overnight at 4 ◦C with antibodies directed against total and phospho-AKT (Ser473), cleaved caspase 3,
cleaved caspase 9, total and phospho-GSK3β (ser 9), cytochrome C, and phospho-VDAC (Cell Signaling,
Beverly, MA, USA); GRP78, CHOP, ATF4 and total and phospho-PERK (Santa Cruz Biotechnology,
Santa Cruz, California, USA), HMGB-1(Abcam, Milton, Cambridge, UK), and β actin (Sigma
Chemical, St. Louis, MO, USA). After washing, membranes were incubated with appropriate
peroxidase-conjugated secondary antibody for 1 h. Immuno-labeled bands were detected using
Western-Bright ECL-HRP Substrate (Advansta, Menlo Park, CA, USA) and quantified using the
Quantity One software for image analysis. Results were expressed as densitometry ratios between the
protein of interest and the loading control (β-actin).
4.3.7. Heme-Oxygenase (HO-1) Immunohistochemistry
Frozen liver sections (16 µm thick) were fixed in pre-cooled acetone for 10 min at room temperature.
After washing and permeabilization, HO-1 was detected by using a primary HO-1 antibody (Sigma
Chemical). Following, rinsing in Phosphate-buffered saline solution (PBS) permeabilization was
performed again three times with 0.5% Triton X-100 for 10 min. The secondary antibody (Alexa 488
Fluor labeled, donkey anti-rabbit, Invitrogen, Waltham, MA, USA) was applied at the dilution of
1:400 in the blocking solution for 50 min at room temperature. Negative controls were prepared as
previously described [8] and images were detected using Nikon Eclipse E1000 fluorescence microscope
(Nikon Instruments Inc., Melville, NY, USA).
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4.3.8. Heat Shock Protein (HSP-70) Immunohistochemistry
Frozen liver sections (16 µm thick) were fixed in 1% p-formaldehyde for 10 min at room
temperature. After washing with PBS, post-fixation with ethanol:acetic acid 2:1 for 5 min and
permeabilization twice with 0.5% Triton X-100 for 15 min were performed. Antibody especific binding
was blocked for 1 h in PBS with 10% normal goat serum, 3% bovine serum albumin, 1.5% NaCl and
0.5% Triton X-100 for 1 h. Immunohistochemistry analyses were performed using HSP70 (primary
anti-body from BD Science, San Jose, CA, USA) and Alexa 594 Fluor labelled (secondary antibody from
Invitrogen, USA), as previously described [8]. Negative controls were prepared by replacing the first
antibody with phosphate saline buffer. Images were obtained with a Nikon Eclipse E1000 fluorescence
microscope [8].
4.4. Statistics
Data are expressed as means ± standard error, and were compared statistically by variance
analysis, followed by the Student–Newman–Keuls test (Graph Pad Prism software, Inc., La Jolla, CA,
USA). p < 0.05 was considered significant.
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